The evidence for laser treatments to the vulvo‐vagina: Making sure we do not repeat past mistakes

Following menopause, up to 49% of women will experience genitourinary symptoms such as vaginal itching, dryness, dyspareunia and incontinence as a result of oestrogen deficiency. Treatments such as vaginal lubricants and moisturisers only temporarily relieve symptoms, while local oestrogen treatments are often unacceptable or unsafe for many women. Recently, a novel laser treatment has been proposed as a non‐invasive, long‐term solution to vulvo‐vaginal and urinary symptoms. While preliminary histological results have been promising, its therapeutic, clinical effect has yet to be determined. However, despite the scarcity of evidence for its safety and long‐term benefit, laser treatments are widely marketed for a range of genitourinary symptoms, with high uptake by both clinicians and women alike. This review aims to examine the evidence for laser treatments to the vulvo‐vagina and to evaluate its safety and efficacy. Our results include 17 studies investigating the effect of laser therapy for vulvo‐vaginal symptoms, seven for its effects on urinary incontinence and four for histology. These are limited to non‐randomised, observational data with small sample sizes between 15 to 175 women and follow‐up duration from none to two years. As such, strong evidence for laser efficacy and safety is limited and warrants more robust, placebo‐controlled, randomised trials before widespread implementation.